MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0003581
Arretta Pharmaceuticals Private Limited
Arretta Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹29.77 Lakh
▼ 60% YoY
Net loss · FY 2024
₹8.68 Lakh
Net margin -29.2%
EBITDA · FY 2024
-₹8.68 Lakh
EBITDA margin -29.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹45 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Arretta Pharmaceuticals Private Limited
Data last updated:
Arretta Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51101MH2015PTC263977. Its GSTIN is 27AANCA4350R1Z1 (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Navin Shekhar and Shiwani Navin Shekhar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.77 Lakh, a decline of 60% compared to the previous year. For the same year it recorded a net loss of ₹8.68 Lakh (net margin -29.2%) and EBITDA of -₹8.68 Lakh (EBITDA margin -29.2%). Revenue has declined at a compounded annual rate (CAGR) of 43% over three years.
As per MCA filings, the company has open charges of ₹45 Lakh on record.
Arretta Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0003581). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51101MH2015PTC263977
Registration Number 263977
Incorporation Date 30 April 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0003581
Recognitions & Rankings of Arretta Pharmaceuticals
Contact details
Arretta Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address301/B Bldg No 1 Ng Suncity Chs Ltd Thakur Village Phase II Near Farid Esta, Te, Mumbai, Maharashtra, India – 400101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Arretta Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Arretta Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Arretta Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Arretta Pharmaceuticals Private Limited, buy the company report.
Financials of Arretta Pharmaceuticals Private Limited
FY 2024 filings availableArretta Pharmaceuticals Private Limited reported revenue of ₹29.77 Lakh (down 60% YoY) for FY 2024.
Revenue · FY 2024
₹29.77 Lakh ▼ 60%
Net loss · FY 2024
₹8.68 Lakh margin -29.2%
EBITDA · FY 2024
-₹8.68 Lakh margin -29.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 60%
3 years · compounded
▼ 43%
EBITDA CAGR growth
3 years · compounded
▼ 64%
Revenue has declined at a compounded annual rate (CAGR) of 43% over three years, including a 60% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -29.2% | ||||
| Net Profit Margin | -29.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arretta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Arretta Pharmaceuticals Private Limited
Arretta Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Navin Shekhar | Director | 30 Apr 2015 | 11 Years 5 Months | Current |
| Shiwani Navin Shekhar | Director | 30 Apr 2015 | 11 Years 5 Months | Current |
Auditor
Arretta Pharmaceuticals Private Limited is audited by JAIN LOKESH & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN LOKESH & CO | FY 2020 | 133209W |
Shareholding
The shareholding of Arretta Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Arretta Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹45 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Oct 2020 | 100383310 | Others | ₹45 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Arretta Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arretta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arretta Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANCA4350R1Z1 | Maharashtra | Active | 12 Sep 2019 |
| 10AANCA4350R1ZG | Bihar | Active | 01 Nov 2019 |
To see the full GST registrations and return filing status of Arretta Pharmaceuticals Private Limited, buy the company report.
Recent activity
Arretta Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Navin Shekhar was appointed as Director on 30 Apr 2015.
AGM
Arretta Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Arretta Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 45.00 Lakh with Charge ID 100383310 was registered on 19 Oct 2020.
Appointed
Navin Shekhar was appointed as Director.
Appointed
Shiwani Navin Shekhar was appointed as Director.
Incorporation
30 Apr 2015
Arretta Pharmaceuticals Private Limited was registered on 30 Apr 2015 with Roc Mumbai & aged 11 years 6 months as per MCA records.
Frequently asked questions
Arretta Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 April 2015 (11+ years old) and is registered under CIN U51101MH2015PTC263977.
Arretta Pharmaceuticals has 2 current directors:
- Navin Shekhar - Director
- Shiwani Navin Shekhar - Director
The latest financial statements of Arretta Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Arretta Pharmaceuticals is 27AANCA4350R1Z1, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AANCA4350R1ZG (Bihar).
The CIN (Corporate Identification Number) of Arretta Pharmaceuticals is U51101MH2015PTC263977. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arretta Pharmaceuticals was incorporated on 30 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Navin Shekhar was appointed as Director on 30 Apr 2015. Shiwani Navin Shekhar was appointed as Director on 30 Apr 2015.
Yes, Arretta Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0003581).
The registered office of Arretta Pharmaceuticals is at 301B Bldg No 1 Ng Suncity Chs Ltd Thakur Village Phase II Near Farid Esta, Te, Mumbai, Maharashtra, India – 400101.
Arretta Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.